RecruitingNCT06266611
Hemp-derived CBD with or without THC for symptoms during cancer care
About this title
Read the official source — NCT06266611Medication studyAges 25+United StatesAnxiety
Understand this study
Who could participate?
Listed age limits: from 25 years.
- Listed locations
- AuroraSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: September 16, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 185
- Sponsor
- University of Colorado, Boulder
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- Over 25 Years
- Official registry ID
- NCT06266611
- Official title
Show the full official title
Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Aurora
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Colorado, Boulder, a university.
Does this study involve medication?
Yes. The study involves medication, including fsCBD Cannabidiol, Placebo and bsCBD Cannabidiol.
Who can participate?
Listed age limits: from 25 years.
Is this study still recruiting?
The registry lists this study as recruiting.
